Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies
Stefano Ballestri, Alessandro Mantovani, Christopher D. Byrne, et al.
Metabolism and Target Organ Damage (2021)
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 32
Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults
Yiting Liu, Wei Wang
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 31
Validation of five hepatic steatosis algorithms in metabolic‐associated fatty liver disease: A population based study
Yuxiu Liu, Shiying Liu, Jiaofeng Huang, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 5, pp. 938-945
Closed Access | Times Cited: 26
Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study
Yaqin Wang, Jiangang Wang, Lei Liu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke
Chen Shen, Hongliang Xue, Rong Huang, et al.
Diabetes & Metabolism (2023) Vol. 49, Iss. 5, pp. 101468-101468
Closed Access | Times Cited: 13
Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge
Mohamad Jamalinia, Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 5
Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis
Kasra Pirahesh, Ali Zarrinnia, Leila Nikniaz, et al.
Preventive Medicine Reports (2025) Vol. 50, pp. 102968-102968
Open Access
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Díaz, Juan Pablo Arab, Francisco Idalsoaga, et al.
Annals of Hepatology (2025), pp. 101903-101903
Open Access
Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population
Ruirui Ren, Yang Zheng
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 7, pp. 1349-1357
Closed Access | Times Cited: 8
NAFLD does not increase the risk of incident dementia: A prospective study and meta-analysis
Hangkai Huang, Zhening Liu, Jiarong Xie, et al.
Journal of Psychiatric Research (2023) Vol. 161, pp. 435-440
Closed Access | Times Cited: 8
Nonalcoholic fatty liver disease without overlapping metabolic‐associated fatty liver disease and the risk of incident type 2 diabetes
Yoosun Cho, Yoosoo Chang, Seungho Ryu, et al.
Liver International (2023) Vol. 43, Iss. 11, pp. 2445-2454
Open Access | Times Cited: 7
Precision medicine in nonalcoholic fatty liver disease
Amedeo Lonardo
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 7, pp. 1175-1178
Open Access | Times Cited: 12
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes
Alessandro Mantovani, Alessandro Csermely, Antonio Taverna, et al.
Diabetes & Metabolism (2022) Vol. 49, Iss. 2, pp. 101416-101416
Open Access | Times Cited: 12
Comparison of Clinical Characteristics and Outcomes of MAFLD and NAFLD in Chinese Health Examination Populations
Xin Xu, Xiao‐Hua Zhou, Ting Tian, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 6
Expanding donor pool for live donor liver transplantation: utilization of donors with non-alcoholic steatohepatitis after optimization
Viniyendra Pamecha, Nilesh Patil, Kumaraswamy Parthasarathy, et al.
Langenbeck s Archives of Surgery (2022) Vol. 407, Iss. 4, pp. 1575-1584
Closed Access | Times Cited: 10
From NAFLD to HCC: Advances in noninvasive diagnosis
Qinchen Xu, Maoxiao Feng, Yidan Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115028-115028
Open Access | Times Cited: 6
Skipping breakfast is associated with an increased long‐term cardiovascular mortality in metabolic dysfunction‐associated fatty liver disease (MAFLD) but not MAFLD‐free individuals
Jiarong Xie, Hangkai Huang, Yishu Chen, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 55, Iss. 2, pp. 212-224
Closed Access | Times Cited: 14
Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: A panel-data analysis
Alessandro Mantovani, Chiara Zusi, Alessandro Csermely, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 5, pp. 1093-1097
Closed Access | Times Cited: 5
Adiposity, hepatic steatosis, and metabolic health transitions in people with obesity: Influences of age and sex
Alvaro M. Netto, Nea Miwa Kashiwagi, Carlos André Minanni, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 6, pp. 1149-1157
Closed Access | Times Cited: 4
MASLD: predictive value for liver-related events and extra-hepatic complications
Mohamad Jamalinia, Amedeo Lonardo
Expert Review of Gastroenterology & Hepatology (2024), pp. 1-4
Open Access | Times Cited: 1
Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease
Yueru Yang, Shuhui Wsan, Linling Yu, et al.
Diabetes & Metabolism (2024), pp. 101602-101602
Closed Access | Times Cited: 1
Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females
Masahiro Sogabe, Toshiya Okahisa, Takeshi Kurihara, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Influence of alcohol on newly developed metabolic dysfunction-associated fatty liver disease in both sexes: A longitudinal study
Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 5, pp. 810-816
Open Access | Times Cited: 3
Metabolic‐associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
Jiwon Chang, Yoosoo Chang, Yoosun Cho, et al.
Liver International (2023) Vol. 43, Iss. 11, pp. 2548-2559
Open Access | Times Cited: 3
Nonalcoholic fatty liver disease and risk of intracerebral hemorrhage
Jian Wu, Jiahuan Guo, Anxin Wang, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 11, pp. 2561-2567
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top